![]() |
|
|
Vol. 289, Issue 2, 895-900, May 1999
Department of Pharmacology and Toxicology, Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada
| |
Abstract |
|---|
|
|
|---|
Our objective was to determine whether a stabilized form of nitric oxide (NO) such as an S-nitrosothiol, rather than NO itself, is the vasoactive metabolite produced when glyceryl trinitrate (GTN) interacts with vascular smooth muscle. In a control study, NO formation was measured by a chemiluminescence-headspace gas method during the incubation of a prototype S-nitrosothiol, namely, S-nitroso-N-acetylpenicillamine (SNAP), in Krebs' solution. NO formation from SNAP was increased when the incubation was carried out in the presence of UV light, indicating that homolytic photolysis of the S-nitrosothiol had occurred. When GTN was incubated with bovine pulmonary artery (BPA) in the absence of UV light, NO was not measurable until 5 min of incubation. By contrast, in the presence of UV light, NO was measurable as early as 0.5 min, and by 5 min, it was higher than that observed in the absence of UV light. BPA rings were relaxed with SNAP and GTN in the absence of UV light, and EC50 values of 0.24 ± 0.28 µM and 10 ± 6 nM, respectively, were observed. In the presence of UV light, the vasodilator response of BPA to SNAP and GTN was attenuated, and EC50 values of 2.7 ± 3.0 µM and 49 ± 23 nM, respectively, were observed. Our results are consistent with the idea that GTN biotransformation by vascular smooth muscle results in the production of a stabilized form of NO, possibly an S-nitrosothiol, and that degradation of this metabolite by UV light results in NO formation accompanied by decreased vasodilation.
| |
Introduction |
|---|
|
|
|---|
Despite
its clinical use for 150 years, the mechanism by which glyceryl
trinitrate (GTN) induces vasorelaxation is not completely understood.
It has been hypothesized that GTN is a prodrug that requires
endothelium-independent biotransformation to the free radical, nitric
oxide (NO) (Ignarro et al., 1989
). This free radical can activate
soluble guanylyl cyclase to increase cGMP formation and promote blood
vessel relaxation (Murad et al., 1978
; Ignarro et al., 1989
). As such,
it appears that GTN acts as a pharmacological replacement for
endothelium-derived relaxing factor, which is also thought to be NO
(Palmer et al., 1987
; Furchgott, 1988
).
In support of this NO-prodrug hypothesis, concentrations of the
denitrated metabolite, glyceryl dinitrate, and cGMP have been found to
increase during incubation of GTN with vascular smooth muscle at time
points concurrent with vasodilation (Brien et al., 1988
). Furthermore,
using a chemiluminescence-headspace gas method, NO has been measured
from the incubation of vascular smooth muscle with GTN (Marks et al.,
1992
; 1995
). However, NO was not measurable until relaxation was nearly
completed. In another set of experiments, it was observed that
incubation of vascular smooth muscle with GTN served as a source of a
diffusible relaxing factor that could relax a nonvascular smooth muscle
bioassay tissue (Hussain et al., 1994
). The relaxing factor was
sensitive to hemoglobin but not sensitive to superoxide (Hussain et
al., 1994
, 1996
). Taken together, these results suggest that a
conjugate of NO, such as an S-nitrosothiol, rather than NO
itself, is responsible for GTN-induced vasodilation.
S-Nitrosothiols of the generic structure RSNO, which
are formed by reaction of NO and sulfhydryl-containing compounds,
possess many of the pharmacological properties of GTN, including
vasorelaxation (Ignarro et al., 1981
; Mathews and Kerr, 1993
) and
inhibition of platelet aggregation (Mellion et al., 1983
). Furthermore,
an S-nitrosothiol was previously proposed to be an active
metabolite produced by vascular biotransformation of GTN (Ignarro et
al., 1981
). Given the unstable chemical nature of
S-nitrosothiols, the detection of such compounds has been
elusive until recently, when investigators quantified endogenous
S-nitrosothiols in blood plasma and pulmonary fluids
(Stamler et al., 1992a
; Gaston et al., 1993
). The measurement of
S-nitrosothiols has been achieved by using long-wave UV
light photolysis, resulting in homolytic cleavage of the molecule
yielding thiyl radical and NO, the latter of which is measured
by chemiluminescence (Stamler et al., 1992b
; Welch et al., 1996
). From
such observations, it follows that if an S-nitrosothiol or
S-nitrosothiols are produced during the biotransformation of
GTN by vascular smooth muscle, the exposure to UV light should increase
GTN-derived NO production.
In the present study, the first objective was to determine whether light-sensitive NO conjugate or conjugates are produced during GTN biotransformation by bovine pulmonary artery (BPA) using a UV photolysis-chemiluminescence method. The second objective was to examine the effect of UV photolysis of a putative NO-conjugate on GTN-induced relaxation of vascular smooth muscle.
| |
Materials and Methods |
|---|
|
|
|---|
Drugs and Solutions.
Krebs' solution contained 120 mM NaCl,
5.6 mM KCl, 1.2 mM MgSO4, 1.2 mM
NaH2PO4, 2.5 mM
CaCl2, 25 mM NaHCO3, and 10 mM dextrose; 30 µM EDTA also was added. This solution was bubbled
with 95% O2/5% CO2
(medical grade; Praxair Canada, Inc., Toronto, Ontario, Canada). Stock
solutions of GTN (2.2 × 10
2 M) were
obtained from Omega (Montreal, Quebec, Canada) as Nitroject. S-Nitroso-N-acetylpenicillamine (SNAP) was
obtained from Colour Your Enzyme (Bath, Ontario, Canada). Stock
solutions of SNAP were prepared in Krebs' solution. Working solutions
of the above drugs were prepared on the day of experimentation using
Krebs' solution; the stock and working solutions were kept on ice. A
stock solution of 3.0 M KCl (BDH, Inc., Toronto, Ontario, Canada) was
prepared in deionized water. NO calibration gases (3.2-512 ppm in
N2) and 5% NO/95% N2 were
obtained from Scott Specialty Gases (Troy, MI). All other chemicals
used were of at least reagent grade and were obtained from BDH, Inc.
Preparation of BPA Strips and Rings. Bovine lungs were obtained from a local abattoir immediately after slaughter and immersed in ice-cold Krebs' solution during transport. When used for measurement of NO formation, the secondary branches of the BPA were removed, cleaned of connective tissue and blood, and cut longitudinally. To obviate the effects of endothelium-derived relaxing factor, the endothelial cell layer was removed by gently scraping with a razor blade, and blood vessels were washed with ice-cold Krebs' solution. In experiments in which BPA was used for isometric tension studies, 5-mm-wide rings were cut from the secondary branch of the pulmonary artery, and the endothelium was removed by gently rubbing of the intimal surface with a stainless steel wire for 30 s. Contraction of BPA rings in response to incubation with 1 µM acetylcholine was used as an indicator of endothelium removal.
Measurement of NO Formation.
To measure NO formation from
nitrovasodilators, a modification of the chemiluminescence-headspace
gas method described by Brien et al. (1991
, 1996
) was used. To a
micro-Fernbach flask (total volume, 7.5 ml) we added 3 ml of Krebs'
solution, 100 U/ml superoxide dismutase, and a micro-stir bar to mix
the sample continuously. A BPA strip that had been equilibrated for
1 h in Krebs' solution, bubbled with 95%
O2/5% CO2 at 37°C, was
added to samples requiring tissue. The flask was sealed with a
rubber-sleeve septum (Aldrich Chemical Co., Inc., Milwaukee, WI),
equilibrated at 37°C for 5 min, and then gassed with a stream of 20%
O2/5% CO2/balance
N2 for 5 min at 37°C. With the use of a
gas-tight syringe, SNAP (0.1 or 10 µM) or GTN (100 µM) was injected
through the rubber-sleeve septum into flasks with or without BPA, and
the samples were incubated at 37°C for 10 min. A 400-µl aliquot of
headspace gas was taken from each sample at 0.5, 2, 5, and 10 min and
analyzed for NO using a model 270 B Nitric Oxide Analyzer (Sievers
Research, Inc., Boulder, CO).
= 320-380 nm). The UV lamp (Blak-Ray Lamp, 2 A, 115 V, model B100; Fisher Scientific, San Gabriel, CA) used to generate the long-wave UV light was positioned 5 cm from the reaction vessel. This wavelength range of UV light was
similar to that used by other investigators for homolytic photolysis of
S-nitrosothiols (Welch et al., 1996Relaxation Response of BPA to SNAP and GTN. BPA rings were mounted in water-jacketed quartz-glass tissue baths containing 10 ml of Krebs' solution at 37°C and bubbled with 95% O2/5% CO2. Each BPA ring was connected to a model FT03D force displacement transducer (Grass Instruments, Quincy, MA) such that isometric changes in tension could be recorded using a Grass model 7 polygraph. BPA rings were subjected to 2.0g resting tension and equilibrated for 1 h during which the Krebs' solution in the tissue bath was changed every 15 min. After equilibration, the BPA rings were contracted maximally with 100 mM K+. After washout at 15-min intervals for 1 h, 20 mM K+ was added to obtain a submaximal contraction (60-80% of the maximal tone). After the submaximal contraction had stabilized, cumulative concentration-response curves were determined for SNAP (0.1 nM to 10 µM) or GTN (0.1 nM to 100 µM) incubated with BPA rings in the absence or presence of UV light.
Data Analysis. The data are presented as group ± S.D. mean values. NO formation data were statistically analyzed using a randomized-design, two-way ANOVA for incubation time and UV light exposure. For a significant F statistic (p < .05) for UV light exposure, a Student's t test for unpaired data (two-tailed) was conducted. BPA ring relaxation data, including individual nitrovasodilator concentrations and EC50 values, were analyzed by Student's t test for unpaired data (two-tailed). Two groups of data were considered to be statistically different when p < .05.
| |
Results |
|---|
|
|
|---|
Effect of UV Light on NO Formation From SNAP.
For 10 µM SNAP
in Krebs' solution, there was a time-dependent formation of NO that
was increased (p < .05) when exposed to UV light (Fig.
1). The UV light exposure increased NO
formation by 4.9-, 4.9-, 5.9-, and 8.2-fold, after 0.5, 2, 5, and 10 min of incubation, respectively. Similarly, when 0.1 µM SNAP in
Krebs' solution was exposed to UV light, there were increases
(p < .05) in NO formation at 0.5, 2, 5, and 10 min of
8.8-, 9.5-, 11.2-, and 12.9-fold, respectively (Fig. 1).
|
Effect of UV Light on NO Formation From Interaction of GTN With
L-Cysteine.
Incubation of 100 µM GTN with 1 mM
L-cysteine for 10 min resulted in time-dependent formation
of NO (Fig. 2). When the
GTN-L-cysteine samples were exposed to UV light, there was
an increase (p < .05) in NO formation at all
experimental time points. The increase in NO formation was 2.0-, 1.8-, 1.6-, and 1.9-fold at 0.5, 2, 5, and 10 min of incubation,
respectively.
|
Effect of UV Light on NO Formation During GTN Incubation With
BPA.
Incubation of 100 µM GTN with BPA strips resulted in no
detectable NO after 0.5 and 2 min (Fig.
3). However, in the presence of UV light,
NO formation was measured after 0.5 and 2 min in the amount of 159 ± 45 and 171 ± 37 pmol NO/g tissue (n = 4), respectively. Longer incubation times of 5 and 10 min in the presence of UV light resulted in approximately 2.7- and 6.2-fold increases (p < .05) in NO formation, respectively, compared with
no UV light exposure. The exposure of 100 µM GTN to UV light did not
result in measurable formation of NO, thereby eliminating GTN itself as
the source of UV light-derived NO in the GTN-BPA incubation system.
This finding is consistent with previous observations that GTN per se
is not photoactivated to form NO (Matsunaga and Furchgott, 1991
;
Venturini et al., 1993
).
|
Effect of UV Light on Nitrovasodilator-Induced BPA Relaxation.
The exposure to UV light resulted in photorelaxation of some BPA rings
producing a 10% to 30% decrease in submaximal tone that plateaued
after 5 min. After the BPA rings reached a stable tension,
concentration-response curves were determined for SNAP or GTN. BPA
rings also were incubated with these nitrovasodilator drugs in the
absence of UV light. When BPA rings were incubated with SNAP in the
presence of UV light, SNAP-induced relaxation was attenuated
(p < .05) at nearly all concentrations of SNAP that
were studied (Fig. 4). Furthermore, there
was an increase (p < .05) in the
EC50 value of the SNAP concentration-response curve in the presence of UV light compared with the absence of UV light
(2.7 ± 3.0 versus 0.24 ± 0.28 µM, respectively;
n = 5). It was observed that not only was relaxation
attenuated by UV light but also the ability of BPA rings to maintain
SNAP-induced relaxation was impaired (Fig.
5). Incubation of BPA rings with GTN in
the presence of UV light resulted in attenuation (p < .05) of GTN-induced relaxation at nearly all of the concentrations of
GTN (Fig. 6). As well, the
EC50 value of the GTN concentration-response curve in the presence of UV light was increased (p < .05) compared with the absence of UV light (49 ± 23 versus
10 ± 6 nM, respectively; n = 5).
|
|
|
| |
Discussion |
|---|
|
|
|---|
The purpose of the present study was to test the hypothesis that
vascular smooth muscle, such as BPA, biotransforms organic nitrates to
a vasoactive S-nitrosothiol. The measurement of NO subsequent to UV photolysis of the S-NO bond has been used
to detect S-nitrosothiols in blood plasma (Stamler et al.,
1992a
), and we used a modification of this method in our studies. SNAP was used as a model S-nitrosothiol to test a modification of
the method that was suitable for our requirements. The molar yield of
NO from 10 µM SNAP after a 0.5-min incubation in Krebs' solution increased from 0.48% to 2.3% in the presence of UV light (Fig. 1). In
contrast, the molar yield of NO from 0.1 µM SNAP increased from 6.6%
to 59% in the presence of UV light (Fig. 1). Because many earlier
studies involved the use of millimolar rather than micromolar
concentrations of SNAP, the extent of formation of NO may have been
underestimated with respect to lower, physiologically relevant
concentrations of S-nitrosothiols. Thus, based on the long-wavelength, UV-light-stimulated formation of NO from SNAP, it
appears that the UV photolysis-chemiluminescence method is an
appropriate technique for detecting putative S-nitrosothiols produced by GTN biotransformation during incubation with vascular smooth muscle.
Feelisch and Noack (1987)
proposed that GTN elicits its vasodilator
effects through a nonenzymatic interaction with endogenous thiol-containing compounds, resulting in the formation of a
vasorelaxant S-nitrosothiol. Our results showed a
time-dependent increase in NO formation from the interaction of 100 µM GTN with 1 mM L-cysteine (Fig. 2). The
interaction of GTN and L-cysteine is postulated to result in the formation of
S-nitroso-L-cysteine, but conclusive evidence for
formation of this S-nitrosothiol has not been provided. Because S-nitrosothiols undergo UV photolysis to form NO and
because UV light increases NO formation from the interaction of GTN and L-cysteine, the results are therefore consistent
with formation of an S-nitrosothiol during this reaction.
In the absence of UV light, chemiluminescence-headspace-gas measurement
of NO formation from the incubation of 100 µM GTN with BPA was
possible only after 5 min (Fig. 3). This result is consistent with
previous results obtained in our laboratory (Marks et al., 1992
, 1995
).
In a previous study, the inability to measure NO from GTN on
interaction with vascular smooth muscle at time points concurrent with
vasorelaxation (less than 5 min) led to the proposal that a conjugate
of NO such as an S-nitrosothiol, rather than NO per se, may
be the vasoactive metabolite derived from GTN (Marks et al., 1995
). In
the present study, when GTN was incubated with BPA in the presence of
UV light, NO was measured as early as 0.5 min (Fig. 3). Furthermore, at
5 and 10 min of incubation, NO formation was greater in the presence of
UV light compared with no UV light exposure. Because the wavelength
output of the UV source (320-380 nm) includes the range of 330 to 350 nm, which is capable of S-nitrosothiol homolysis (Butler and
Rhodes, 1997
), it appears therefore that UV light is forming NO from
the photolysis of GTN-derived S-nitrosothiol or
S-nitrosothiols in the BPA incubates. Furthermore, the fact
that NO formation was measurable at 0.5 min, an experimental time point
that coincides with the onset of GTN-induced vasodilation of BPA
(Kawamoto et al., 1990
), supports the concept that an
S-nitrosothiol is the vasoactive metabolite produced during
the biotransformation of GTN by BPA.
GTN biotransformation in vascular tissue results in the production of
intracellular nitrite anion
(NO2
) in addition to NO
(Bennett and Marks, 1984
); therefore, it is possible that enhanced NO
formation from the incubation of GTN with BPA in the presence of UV
light may have resulted from photolytic decomposition of
NO2
to NO (Matsunaga and
Furchgott, 1989
, 1991
). Several factors make this interpretation
unlikely. It has been estimated that vascular smooth muscle contains
micromolar concentration of endogenous NO2
(Bennett and Marks, 1984
),
and in the present study, BPA irradiated with UV light in the absence
of GTN resulted in an apparent NO chemiluminescence signal that was not
different from the background signal produced by Krebs' solution
exposed to UV light (data not shown). Also, it is likely that any NO
derived from intracellular NO2
, either from endogenous
stores or from GTN biotransformation, is rapidly degraded in situ by
superoxide radical anion, which is generated simultaneously during the
photolysis of NO2
(Matsunaga
and Furchgott, 1989
).
An assumption underlying the term "nitrovasodilator" is that
compounds such as SNAP and GTN function through the formation of NO.
Based on this assumption and the observation that UV light photolyzed
SNAP to form NO, it was anticipated that relaxation of BPA by SNAP
would be potentiated by UV light. Instead, it was found that
SNAP-induced relaxation of BPA was attenuated in the presence of UV
light (Fig. 4), with an 11-fold increase in the EC50 value for SNAP-induced relaxation. A
possible explanation for this observation is that SNAP acts as a
carrier of NO to the intracellular target for NO. As the nitrosyl
moiety of a thionitrite compound, rather than as free NO, there would
be less vulnerability of the vasoactive moiety to the inactivating
effects of compounds such as oxygen and superoxide radical anion (Robak
et al., 1992
). If this were the case, then the formation of NO from
SNAP by UV light, before SNAP reached the intracellular target, would
result in diminished vasorelaxation due to increased exposure of NO to inactivating compounds. This interpretation is supported by the observation in the present study that SNAP-induced relaxation of BPA
rings in the absence of UV light reached a stable tension after the
addition of each concentration of SNAP, whereas in the presence of UV
light, SNAP-induced relaxation of BPA rings could not be sustained
(Fig. 5). The inability of the UV-irradiated BPA rings to maintain
SNAP-induced relaxation is consistent with the idea that NO has been
formed from SNAP in that the transient nature of the relaxation is
characteristic of that for NO-induced relaxation of vascular smooth
muscle in tissue bath studies (Furchgott et al., 1992
; Hussain et al.,
1997
). These results are consistent with previous studies in which it
was found that the formation of NO from S-nitrosothiols did
not correlate with S-nitrosothiol-induced relaxation of
vascular smooth muscle (Kowaluk and Fung, 1990
; Mathews and Kerr,
1993
). It is possible that the NO moiety of S-nitrosothiols
never exists as free NO but instead is transferred to a macromolecule
causing S-nitrosylation and activation of the enzymic
activity of the macromolecule. Macromolecule
S-nitrosylations have been studied extensively by
investigators who have demonstrated that this reaction occurs in vitro
and in vivo (Lipton et al., 1993
; Scharfstein et al., 1994
).
Incubation of GTN with BPA rings in the presence of UV light resulted in the attenuation of GTN-induced relaxation (Fig. 6) in a similar manner to that observed for SNAP. There was a 5-fold increase in the EC50 value for GTN-induced relaxation of BPA rings exposed to UV light. Based on the observations for SNAP-induced relaxation of BPA rings in the presence of UV light, it is proposed that attenuation of GTN-induced vasodilation may be the result of homolytic cleavage of an S-nitrosothiol produced during GTN biotransformation by BPA. As discussed previously, this S-nitrosothiol may serve as a carrier of NO to its intracellular target. UV light was less effective in attenuating GTN-induced relaxation of BPA rings compared with SNAP. A possible explanation is that the biotransformation of GTN to a putative S-nitrosothiol would occur intracellularly and be less susceptible to photolysis by UV light than SNAP, an S-nitrosothiol that was administered extracellularly to the BPA.
In summary, when GTN was incubated with BPA in the presence of UV light, there was measurable NO formation at a time that coincided with the onset of vasorelaxation. However, despite enhanced NO formation in the presence of UV light, for GTN incubated with BPA and for SNAP incubated in Krebs' solution, the vasodilator response to these nitrovasodilators was attenuated. In view of the chemical reactivity of NO and the potential for S-nitrosothiols to be transported and converted to NO at a target site of action, our results are more consistent with the idea that a stabilized form of NO such as an S-nitrosothiol, rather than NO itself, is the vasoactive metabolite formed when GTN interacts with vascular smooth muscle.
| |
Acknowledgments |
|---|
We thank Janet LeSarge and Chris Berga for their assistance in preparing the manuscript.
| |
Footnotes |
|---|
Accepted for publication December 21, 1998.
Received for publication July 23, 1998.
1 This work was funded by Operating Grant T-3448 from the Heart and Stroke Foundation of Ontario.
Send reprint requests to: Dr. Kanji Nakatsu, Department of Pharmacology and Toxicology, Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada K7L 3N6. E-mail nakatsuk{at}post.queensu.ca
| |
Abbreviations |
|---|
NO, nitric oxide; GTN, glyceryl trinitrate; BPA, bovine pulmonary artery; SNAP, S-nitroso-N-acetylpenicillamine.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Nunez, V. M. Victor, R. Tur, A. Alvarez-Barrientos, S. Moncada, J. V. Esplugues, and P. D'Ocon Discrepancies Between Nitroglycerin and NO-Releasing Drugs on Mitochondrial Oxygen Consumption, Vasoactivity, and the Release of NO Circ. Res., November 11, 2005; 97(10): 1063 - 1069. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||